Key result
Convulxin stimulation of human platelets significantly upregulated 202 of 401 identified metabolites, highlighting the essential role of glycolysis and 1-carbon metabolism in platelet activation.
Why the study?
Platelet activation involves metabolic pathways to support thrombus growth, and selective targeting of metabolic checkpoints may offer a novel antiplatelet strategy.
Metabolic profiling reveals that glycolysis and 1-carbon metabolism are essential for GP VI-stimulated human platelet activation, suggesting potential novel metabolic checkpoints for antiplatelet strategies.
Answers are grounded in this paper and cite their sources.
Identifies metabolic checkpoints in platelet activation; leaves open whether glycolysis or 1-carbon metabolism can be safely targeted in humans.
BACKGROUND: Evolving evidence suggests that besides signaling pathways, platelet activation involves a complex interplay between metabolic pathways to support thrombus growth. Selective targeting of metabolic checkpoints may inhibit platelet activation and provide a novel antiplatelet strategy. We, therefore, examined global metabolic changes that occur during the transition of human platelets from resting to an activated state to identify metabolites and associated pathways that contribute to platelet activation. METHODS: We performed metabolic profiling of resting and convulxin-stimulated human platelet samples. The differential levels, pathway analysis, and PCA (principal component analysis) were performed using Metaboanalyst. Metascape was used for metabolite network construction. RESULTS: Of the 401 metabolites identified, 202 metabolites were significantly upregulated, and 2 metabolites were downregulated in activated platelets. Of all the metabolites, lipids scored highly and constituted ≈50% of the identification. During activation, aerobic glycolysis supports energy demand and provides glycolytic intermediates required by metabolic pathways. Consistent with this, an important category of metabolites was carbohydrates, particularly the glycolysis intermediates that were significantly upregulated compared with resting platelets. We found that lysophospholipids such as 1-palmitoyl-GPA (glycero-3-phosphatidic acid), 1-stearoyl-GPS (glycero-3-phosphoserine), 1-palmitoyl-GPI (glycerophosphoinositol), 1-stearoyl-GPI, and 1-oleoyl-GPI were upregulated in activated platelets. We speculated that platelet activation could be linked to 1-carbon metabolism, a set of biochemical pathways that involve the transfer and use of 1-carbon units from amino acids, for cellular processes, including nucleotide and lysophospholipid synthesis. In alignment, based on pathway enrichment and network-based prioritization, the metabolites from amino acid metabolism, including serine, glutamate, and branched-chain amino acid pathway were upregulated in activated platelets, which might be supplemented by the high levels of glycolytic intermediates. CONCLUSIONS: Metabolic analysis of resting and activated platelets revealed that glycolysis and 1-carbon metabolism are necessary to support platelet activation.
No takes yet. Share an insight, caveat, or question.
Ghatge et al. (2023) studied this question. Convulxin stimulation vs. Resting platelets was evaluated on Metabolite levels. Convulxin stimulation of human platelets significantly upregulated 202 of 401 identified metabolites, highlighting the essential role of glycolysis and 1-carbon metabolism in platelet activation.
Synapse has enriched 10 related papers. Consider them for comparative context: